30Jul
Increased regulatory scrutiny of foreign direct investments in the healthcare sector
Key Takeaways - - Foreign Direct Investment (FDI) controls are proliferating around the globe. Since the pandemic, “health” has become a particular focus. - Several countries have adapted their existing FDI rules, or introduced new ones, to address concerns about national autonomy and supply chain disruption. Some of these changes are general, but some are specific to healthcare. - Plans for cross-border M&A in the healthcare sector should take close account of potential FDI screening...
By:
Dechert LLP
Related
On 17 June 2020, the European Commission published a White Paper seeking views on three powerful new...
Read More >
Considerations when reviewing your MAC Clause in a COVID-19 Climate - As was the case after the glo...
Read More >
Antitrust agencies around the world are adjusting to the policies and procedures they quickly implem...
Read More >
On January 1, 2020, new arbitration procedures for the American Arbitration Association (AAA) with r...
Read More >
The Illinois Supreme Court recently heard oral argument in a case addressing restrictions on school ...
Read More >
2014 was a good year for the Israeli-Japanese economic relationship. Viber’s USD 900 million acquis...
Read More >